EU, Japan and US: a single development programme for new antibiotics
Regulators from the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), met in Tokyo last month to plot out an approach that would allow drugmakers to conduct a single development plan for new antibiotics.
Representatives of the three regulatory agencies discussed the progress made in their collaboration at a…
View On WordPress












